Eli Lilly and Company NYSE LLY
$307.01 1.05 0.34%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Показатель: 37 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

292.78B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

305.85B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.31
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

953.65M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

11.15 %
Upcoming events Eli Lilly and Company All events
No upcoming events scheduled

Stock chart Eli Lilly and Company

Stock analysis Eli Lilly and Company

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
47.77 19.61
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
32.61 5.00
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
32.41 15.21
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.38 1.38
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
65.69 31.97

Price change Eli Lilly and Company per year

127.05$ 275.87$
Min Max

Summary analysis Eli Lilly and Company

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Eli Lilly and Company

Revenue and net income Eli Lilly and Company

All parameters
Stock news Eli Lilly and Company All news

About company Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; MiNA Therapeutics Limited; Verge Genomics; and The Banner Alzheimer's Institute, as well as Kumquat Biosciences. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Address:
Lilly Corporate Center, Indianapolis, IN, United States, 46285
Company name: Eli Lilly and Company
Issuer ticker: LLY
ISIN: US5324571083
Country: USA
Exchange: NYSE
Currency: $
IPO date: 1978-01-13
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.lilly.com

On which stock exchange are Eli Lilly and Company (LLY) stocks traded?

Eli Lilly and Company (LLY) stocks are traded on NYSE.

What is the ticker of Eli Lilly and Company stocks (LLY)?

The stock ticker of Eli Lilly and Company’s stocks or in other words, the code is LLY. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Eli Lilly and Company (LLY) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Eli Lilly and Company (LLY) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Eli Lilly and Company (LLY) stocks traded?

Eli Lilly and Company (LLY) stocks are traded on the NYSE exchange in dollars.

What is the price of Eli Lilly and Company (LLY) stocks today?

The current price of Eli Lilly and Company stocks on 26.05.2022 is 307.01 dollars. per share.

What is the dynamics of Eli Lilly and Company (LLY) stocks from the beginning of the year?

Eli Lilly and Company (LLY) quotes have increased by 0% from the beginning of the year up to 307.01 dollars. per 1 stocks.

How much did Eli Lilly and Company (LLY) stocks increase in мае 2022?

This month Eli Lilly and Company (LLY) quotes have increased by 0% to 307.01 dollars. per share.

How much are Eli Lilly and Company (LLY) stocks worth?

Today, on October, 26.05.2022 Eli Lilly and Company’s (LLY) stocks cost 307.01 dollars..

What is the market capitalization of Eli Lilly and Company (LLY)?

Capitalization is the market value of Eli Lilly and Company (LLY) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 26.05.2022, the market capitalization of Eli Lilly and Company (LLY) is estimated at about 292781007530 dollars.